Dealing in Securities by Directors, Company Secretary and Directors of a major subsidiary ASPEN PHARMACARE HOLDINGS LIMITED (Incorporated in the Republic of South Africa) Registration number 1985/0002935/06 Share code: APN ISIN: ZAE000066692 ("Aspen" or "the Company") DEALING IN SECURITIES BY DIRECTORS, COMPANY SECRETARY AND DIRECTORS OF A MAJOR SUBSIDIARY In compliance with paragraph 3.63 of the Listings Requirements of the JSE Limited, disclosure is made of the following information: DIRECTORS OF THE COMPANY Director : Stephen Bradley Saad Date of transaction : 14 October 2013 Nature of transaction : Acceptance of deferred incentive bonus shares (vesting after three years) Number of securities : 9 675 Class of securities : Ordinary shares Grant price : R264.13 Value of Transaction : R2 555 457.75 Nature of interest : Direct beneficial Clearance obtained : Yes Director : Michael Guy Attridge Date of transaction : 14 October 2013 Nature of transaction : Acceptance of deferred incentive bonus shares (vesting after three years) Number of securities : 8 000 Class of securities : Ordinary shares Grant price : R264.13 Value of Transaction : R2 113 040 Nature of interest : Direct beneficial Clearance obtained : Yes COMPANY SECRETARY OF THE COMPANY Company Secretary : Riaan Verster Date of transaction : 14 October 2013 Nature of transaction : Acceptance of deferred incentive bonus shares (vesting after three years) Number of securities : 1 443 Class of securities : Ordinary shares Grant price : R264.13 Value of Transaction : R381 139.59 Nature of interest : Direct beneficial Clearance obtained : Yes DIRECTORS OF A MAJOR SUBSIDIARY Director : Sean Capazorio Subsidiary Company : Pharmacare Limited Date of transaction : 14 October 2013 Nature of transaction : Acceptance of deferred incentive bonus shares (vesting after three years) Number of securities : 3 189 Class of securities : Ordinary shares Grant price : R264.13 Value of Transaction : R842 310.57 Nature of interest : Direct beneficial Clearance obtained : Yes Director : Morne Geyser Subsidiary Company : Pharmacare Limited Date of transaction : 14 October 2013 Nature of transaction : Acceptance of deferred incentive bonus shares (vesting after three years) Number of securities : 3 112 Class of securities : Ordinary shares Grant price : R264.13 Value of Transaction : R821 972.56 Nature of interest : Direct beneficial Clearance obtained : Yes Director : Noel Guliwe Subsidiary Company : Pharmacare Limited Date of transaction : 14 October 2013 Nature of transaction : Acceptance of deferred incentive bonus shares (vesting after three years) Number of securities : 4 194 Class of securities : Ordinary shares Grant price : R264.13 Value of Transaction : R1 107 761.22 Nature of interest : Direct beneficial Clearance obtained : Yes All acceptances of deferred bonus shares are deemed to be off-market trades. Durban 14 October 2013 Sponsor Investec Bank Limited Date: 14/10/2013 04:47:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.